ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 6

The Novel Role of Corticotropin-Releasing Hormone and Urocortin1 on Sjogren’s Syndrome

Yuichi Yokoyama1, Kiyoshi Matsui2, Sachie Kitano2, Tetsuya Furukawa3, Masahiro Sekiguchi2, Naoto Azuma2, Masayasu Kitano2, Shinichiro Tsunoda2, Tsuyoshi Iwasaki4 and Hajime Sano2, 1Division of Rheumatology, Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, 2Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan, 3Division ofRheumatology Department of internal medicine, Hyogo College of Medicine, Nishinomiya, Japan, 4Department of Pharmacy, Hyogo University of Health Sciences, Kobe, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: IL-23 and Sjogren's syndrome

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2015

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Corticotropin releasing hormone (CRH) is the principal regulator of hypothalamus pituitary adrenal (HPA) axis. CRH and urocortin1 (UCN1) are member of the CRH family. These biological actions are mediated via CRH type1 receptor (CRHR1) and CRH type2 receptor (CRHR2). CRH and UCN1 are expressed in the cells of the immune system. We previously reported that CRH closely connected with the pathogenesis of RA. However, the function of CRH and UCN1 are poorly understood in autoimmune disease. On the other hand, recently, it was reported that IL-21 plays an important role on Sjogren’s syndrome (SS). The aim of this study is to reveal the biological function of CRH and UCN1 inducing IL-21 in SS.

Methods:

We investigated the expression of CRH, UCN1, CRHR1 and CRHR2 by immunohistochemistry (IHC) and reverse transcription with the polymerase chain reaction (RT-PCR) in the salivary gland of patients with SS. We analyzed the function of CRH and UCN1 by NS-SV-DC cell lines, which are immortalized normal salivary gland ductal cells established by transfection with SV40. We examined the mRNA expression of CRH, UCN1, CRHR1, and CRHR2 in NS-SV-DC cell lines by RT-PCR. NS-SV-DC cell lines were cultured in the absence or presence of CRH (10-100nM) or UCN1 (10-100nM). After 24h of culture,IL-21 and IL-23 levels were measured by Enzyme-linked immune Sorbent assay (ELISA). We examined the mRNA expression of IL-21, IL-21 receptor, IL-23α and IL-23 receptor in NS-SV-DC stimulated by CRH or UCN1.

Results:

We detected the expression of mRNA and the protein level of CRH, UCN1 and CRHR2 in the SS patient`s salivary gland by RT-PCR and IHC staining. Moreover we found the mRNA expression of CRH, UCN1 and CRHR2 in NS-SV-DC by RT-PCR. The culture supernatants stimulated by CRH or UCN1 in NS-SV-DC cell lines showed that IL-21 and IL-23 levels increased in a dose-dependent manner by ELISA. To stimulate NS-SV-DC cell lines by CRH and UCN1, we investigated the increasing mRNA expression of IL-21 and IL-23α by RT-PCR.

Conclusion:

The known function of IL-21 is facilitating differentiation, proliferation, survival of both B and T cells. IL-21 is elevated in the serum of patients with SS and is expressed by the lymphocytic infiltrating salivary gland. This is the first report that CRH and UCN1 were detected in salivary gland in patient with SS, and that CRH and UCN1 induce IL-21 and IL-23 production in NS-SV-DC cell lines. These results indicate that CRH or UCN1 play a crucial role of the IL-21 or IL-23 induction in salivary gland in pathogenesis of SS. Regulated IL-21 induction via CRH and UCN1 signal may be a novel therapeutic target in SS.


Disclosure: Y. Yokoyama, None; K. Matsui, None; S. Kitano, None; T. Furukawa, None; M. Sekiguchi, None; N. Azuma, None; M. Kitano, None; S. Tsunoda, None; T. Iwasaki, None; H. Sano, None.

To cite this abstract in AMA style:

Yokoyama Y, Matsui K, Kitano S, Furukawa T, Sekiguchi M, Azuma N, Kitano M, Tsunoda S, Iwasaki T, Sano H. The Novel Role of Corticotropin-Releasing Hormone and Urocortin1 on Sjogren’s Syndrome [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-novel-role-of-corticotropin-releasing-hormone-and-urocortin1-on-sjogrens-syndrome/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-novel-role-of-corticotropin-releasing-hormone-and-urocortin1-on-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology